Clinical Trials
Human stem cells heal the hearts of rats
Survival cocktail&8217; helped repaired hearts thrive in experiment
Date:
08/26/2007
, Publication:
MSNBC
, Author:
Reuters
http://www.msnbc.msn.com/id/20450144/
Trial vaccine may slow breast cancer tumors
Serum tailor-made from patients&8217; immune cells looks safe, researchers say
Date:
08/17/2007
, Publication:
MSNBC
, Author:
Reuters
http://www.msnbc.msn.com/id/20325339/
FDA is rejecting more new drugs than in past
Agency is 'more cautious' in wake of Vioxx problems, expert says
Date:
08/17/2007
, Publication:
MSNBC
, Author:
Associated Press
http://www.msnbc.msn.com/id/20321830/
Update on Investigational Alzheimer's Drug
Voyager Pharmaceutical Corp recently informed its shareholders of preliminary results from a trial of an investigational drug to treat Alzheimer's disease (AD).
Date:
07/31/2007
, Publication:
Pharmacy Times
, Author:
Susan Farley
http://www.pharmacytimes.com/Article.cfm?Menu=1&ID=4866
Another Statin Well-tolerated for High Cholesterol
In a multinational, placebo-controlled trial, rosuvastatin proved to be well-tolerated in patients with dyslipidemia
Date:
07/31/2007
, Publication:
Pharmacy Times
, Author:
Susan Farley
http://www.pharmacytimes.com/Article.cfm?Menu=1&ID=4862
Birth Control Drug Promoted as Acne Treatment
The makers of the oral contraceptive drospirenone/ethinyl (YAZ) will be marketing their drug as a treatment for moderate acne in women
Date:
07/31/2007
, Publication:
Pharmacy Times
, Author:
Susan Farley
http://www.pharmacytimes.com/Article.cfm?Menu=1&ID=4859
Combination Vaccine Shows Good Results
An investigational drug from Glaxo-SmithKline that is a combination diphtheria/tetanus/inactive poliovirus (DTaPIPV) vaccine demonstrated a good immune response
Date:
07/31/2007
, Publication:
Pharmacy Times
, Author:
Susan Farley
http://www.pharmacytimes.com/Article.cfm?Menu=1&ID=4864
Levofloxacin as Effective as Ciprofloxacin for cUTI, Acute Pyelonephritis
A once-daily, 750-mg dose of levofloxacin (Levaquin) taken for 5 days has been shown to be as effective as a 10-day, 400- to 500-mg regimen of ciprofloxacin for the treatment of complicated urinary tract infections
Date:
07/31/2007
, Publication:
Pharmacy Times
, Author:
Susan Farley
http://www.pharmacytimes.com/Article.cfm?Menu=1&ID=4865
Buffered Form of Sevelamer Carbonate Exhibits Promise
Genzyme's sevelamer carbonate (Renvela) successfully and significantly reduced serum phosphorus for hyperphosphalemic patients who have chronic kidney disease
Date:
07/31/2007
, Publication:
Pharmacy Times
, Author:
Susan Farley
http://www.pharmacytimes.com/Article.cfm?Menu=1&ID=4863
FDA Statement on Gene Therapy Clinical Trial
Targeted Genetics notified FDA earlier that a patient in its trial experienced a serious adverse event.
Date:
07/26/2007
, Publication:
FDA Statement
, Author:
FDA
http://www.fda.gov/bbs/topics/NEWS/2007/NEW01672.html
< Previous
Page 3 of 12
Next >
Search returned 119 items.
|
Sponsored Links
Clinical Researchers, others from
subscriber lists and assoc's.
www.biotechmedia.com
Reach these Drug Developers
Via Email or Mail List Rentals
www.biotechmedia.com
This twice-monthly news magazine
reports on all phases of pharmacy
www.drugtopics.com
|